基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 循环系统用药 防治心绞痛药 盐酸替罗非班 盐酸替罗非班
  • 盐酸替罗非班

盐酸替罗非班

Tirofiban Hydrochloride
陕西 更新日期:2022-07-08

XI’AN WANLONG PHARMACEUTICAL CO.,LTD

非会员
联系人:raffia chou
电话:029-81881044拨打
手机:13259794374 拨打
邮箱:raffiachou@hotmail.com

产品详情:

中文名称:
盐酸替罗非班
英文名称:
Tirofiban Hydrochloride
CAS号:
142373-60-2
产地:
陕西、西安
纯度规格:
≥99%

Product Name

Tirofiban Hydrochloride

Synonyms

TirofibanhydrochlorideHCl;N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine hydrochloride;L 700462;L-Tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, monohydrochloride;N-(Butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride;

CAS:

142373-60-2

MF

C22H39ClN2O6S

MW

495.07

Tirofiban Hydrochloride;API;avtive pharmaceutical ingredients

公司简介

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most

成立日期 (29年)
注册资本 7500.000000万
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂
主营行业 医药中间体,原料药

盐酸替罗非班相关厂家报价 更多

内容声明
拨打电话 立即询价